atazanavir sulfate has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W; Li, D; Tian, J; Zhang, G; Zhang, X | 1 |
| Barassi, A; Brandolini, M; Cusato, M; D'Arminio Monforte, A; Gulminetti, R; Maserati, R; Melzi D'Eril, GV; Regazzi, M; Sighinolfi, L; Tinelli, C; Villani, P | 1 |
2 other study(ies) available for atazanavir sulfate and Cirrhosis
| Article | Year |
|---|---|
Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis.
Topics: Administration, Oral; Animals; Atazanavir Sulfate; Cell Line; Cell Proliferation; Collagen; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart; Hypertrophy; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Time Factors | 2018 |
Therapeutic monitoring and variability of atazanavir in HIV-infected patients, with and without HCV coinfection, receiving boosted or unboosted regimens.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Drug Monitoring; Female; Fibrosis; Hepacivirus; Hepatitis C; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Retrospective Studies; Ritonavir | 2011 |